Concepedia

Bärbel Matthey

BM

5

Publications

289

Citations

5

H-Index

1999

Active since

Affiliations

University of Cologne(Current)

University Hospital Cologne

Bärbel Matthey is an author at University of Cologne specializing in biotechnology, protein engineering, and microbiology.

Top concepts

Publications per year

1999–2002

5

Publications

5

A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma.

Roland Schnell, Oliver Staak, Peter Borchmann et al. · PubMed · 2002 · 136 citations

, , +16

Ki-4(scFv)–ETA′, a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice

Stefan Barth, Michael Hühn, Bärbel Matthey et al. · Blood · 2000 · 80 citations

A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteins

Bärbel Matthey, Andreas Engert, Alexander Klimka et al. · Gene · 1999 · 38 citations

, , +8

Inhibition of metalloproteinases enhances the internalization of anti‐CD30 antibody Ki‐3 and the cytotoxic activity of Ki‐3 immunotoxin

Hinrich P. Hansen, Bärbel Matthey, Stefan Barth et al. · International Journal of Cancer · 2001 · 21 citations

Ki-4(scFv)–ETA′, a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice

Stefan Barth, Michael Hühn, Bärbel Matthey et al. · Blood · 2000 · 14 citations

Rows per page

1–5 of 5